找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊MOLECULAR THERAPY 2024/2025影响因子:12.176 (MOL THER) (1525-0016). (MEDICINE, RESEARCH & EXPERIMENTAL)(医学、研究和实验)Scien

[复制链接]
楼主: 使醉
发表于 2025-3-23 10:48:26 | 显示全部楼层
Submitted on: 06 June 2021. Revised on: 23 June 2021. Accepted on: 07 July 2021. MOLECULAR THERAPY---CELL PRESS
发表于 2025-3-23 16:06:41 | 显示全部楼层
Submitted on: 05 April 2001. Revised on: 10 May 2001. Accepted on: 21 May 2001. MOLECULAR THERAPY
发表于 2025-3-23 20:55:48 | 显示全部楼层
Submitted on: 29 June 2013. Revised on: 11 July 2013. Accepted on: 31 July 2013. MOLECULAR THERAPY---CELL PRESS
发表于 2025-3-23 22:41:36 | 显示全部楼层
发表于 2025-3-24 06:11:55 | 显示全部楼层
发表于 2025-3-24 09:53:53 | 显示全部楼层
Submitted on: 27 December 2004. Revised on: 08 January 2005. Accepted on: 15 January 2005. MOLECULAR THERAPY---CELL PRESS
发表于 2025-3-24 11:03:09 | 显示全部楼层
Submitted on: 20 July 2020. Revised on: 26 August 2020. Accepted on: 17 September 2020. MOLECULAR THERAPY
发表于 2025-3-24 18:31:01 | 显示全部楼层
Submitted on: 08 March 2016. Revised on: 03 April 2016. Accepted on: 19 April 2016. MOLECULAR THERAPY
发表于 2025-3-24 20:51:03 | 显示全部楼层
Submitted on: 14 April 2002. Revised on: 23 April 2002. Accepted on: 28 April 2002. MOLECULAR THERAPY---CELL PRESS
发表于 2025-3-25 01:31:26 | 显示全部楼层
Submitted on: 22 March 2009. Revised on: 02 May 2009. Accepted on: 11 May 2009. MOLECULAR THERAPY
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 04:46
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表